| Review: S100B protein in neurodegenerative disorders. | |
| | |
MedLine Citation:
|
PMID: 21303299 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract "Classic" neurodegenerative disorders, such as Alzheimer's disease and amyotrophic lateral sclerosis share common pathophysiological features and involve progressive loss of specific neuronal populations, axonal or synaptic loss and dysfunction, reactive astrogliosis, and reduction in myelin. Furthermore, despite the absence of astrogliosis, impaired expression of astrocyte- and oligodendrocyte-related genes has been observed in patients with major psychiatric disorders, including schizophrenia and mood disorders. Because S100B is expressed in astrocytes and oligodendrocytes, its concentration in cerebrospinal fluid (CSF) or serum has been considered a suitable surrogate marker for the diagnostic or prognostic assessment of neurodegeneration. This review summarizes previous postmortem, CSF and serum studies regarding the role of S100B in this context. A general drawback is that only small single-center studies have been performed. Many potential confounding factors exist because of the wide extra-astrocytic and extracerebral expression of S100B. Due to lack of disease specificity, reliance on S100B concentrations for differential diagnostic purposes in cases of suspected neurodegenerative disorders is not recommended. Moreover, there is no consistent evidence for a correlation between disease severity and concentrations of S100B in CSF or serum. Therefore, S100B has limited usefulness for monitoring disease progression. |
| | |
Authors:
|
Johann Steiner; Bernhard Bogerts; Matthias L Schroeter; Hans-Gert Bernstein |
Related Documents
:
|
23002869 - Universal conductance fluctuations in dirac materials in the presence of long-range dis... 12952049 - Arthritis and related diseases of the foot and ankle: rehabilitation and biomechanical ... 17451809 - Symptoms of neurasthenia following earthquake trauma: re-examination of a discarded syn... 12499939 - Fibular hemimelia: a new classification system. 2218589 - Osteochondrosis dissecans of the glenoid. 15841599 - Questionnaire for usability evaluation of orthopaedic shoes: construction and reliabili... 21304199 - Tuberculosis of nose and palate with vanishing uvula. 11504599 - The significance of type 1 fiber atrophy (hypotrophy) in childhood neuromuscular disord... 19731619 - Spondyloarthritis, diffuse idiopathic skeletal hyperostosis (dish) and chondrocalcinosis. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-9 |
Journal Detail:
|
Title: Clinical chemistry and laboratory medicine : CCLM / FESCC Volume: - ISSN: 1434-6621 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9806306 Medline TA: Clin Chem Lab Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Psychiatry, University of Magdeburg, Magdeburg, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practic...
Next Document: Biomarkers in Alzheimer's disease.